Skip to main content
Clinical Trials/NCT03599479
NCT03599479
Completed
Not Applicable

The Efficacy of Virtual Reality Experiences on Acute Pain and Distress Caused by Fluoroscopic Pain Intervention in Chronic Pain Patients - A Randomized Controlled Clinical Trial

Seoul National University1 site in 1 country44 target enrollmentDecember 27, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Virtual Reality
Sponsor
Seoul National University
Enrollment
44
Locations
1
Primary Endpoint
11-point scale pain score
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The aim of this study is to evaluate the efficacy of virtual reality experiences on acute pain and distress caused by fluoroscopic pain intervention in chronic pain patient.

Detailed Description

The investigators perform lots of interventions for patients. But unfortunately, patients cannot help being exposed to the acute pain and fear during the interventions. "Virtual Reality(VR)" is a state-of-art advanced technology, which is now being extended to various medical fields such as pain management, dental treatment, body rehabilitation and cancer pain. There is no study that have conjugated the virtual reality experience for patients' acute pain and anxiety which occurs during the pain interventions. So the investigators like to evaluate the effects of virtual reality experience on acute pain and anxiety precipitated by the pain interventions.

Registry
clinicaltrials.gov
Start Date
December 27, 2018
End Date
January 2, 2021
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jeeyoun Moon

Associate professor

Seoul National University

Eligibility Criteria

Inclusion Criteria

  • If all of the following conditions are met :
  • Patient who has chronic pain lasting more than 3 months and whose pain doctor determined that he or she needs following fluoroscopic pain intervention : Lumbar sympathetic ganglion block (LSGB), Fluoroscopic-guided pulsed radiofrequency ablation (pRF), Fluoroscopic-guided radiofrequency thermocoagulation (hRF)
  • Adults who are at least 20 years of age
  • Patients whose American Society of Anesthesiologists(ASA) physical status is classified as 1 or
  • A person who voluntarily agrees to participate in this clinical trial and has agreed in informed consent.

Exclusion Criteria

  • If the subject falls under any of the following conditions :
  • Patients who cannot have virtual reality experience due to hearing or visual impairment
  • If the patient has difficulty communicating due to lack of cognitive ability
  • Patients that examiners deemed unsuitable for this trial

Outcomes

Primary Outcomes

11-point scale pain score

Time Frame: 15min after the procedure

11-point scale pain score was assessed by the patient during the fluoroscopic-guided intervention, 0-10. 0 means no pain, 10 means the most severe pain one can imagine

Secondary Outcomes

  • Total amount of local anesthetics used to skin infiltration(intraoperative)
  • Vital sign of the patient: Heart rate (beat per minute)(Intraoperative)
  • Vital sign of the patient: electrocardiogram(ECG)(Intraoperative)
  • Net Promotor Score (NPS) by physician(15min after the procedure)
  • Hamilton Anxiety rating score (HAM-A)(15min after the procedure)
  • Net Promotor Score (NPS) by patient(15min after the procedure)
  • Total procedural time(intraoperative)
  • Vital sign of the patient: Percutaneous oxygen saturation(SPO2,%)(Intraoperative)
  • Vital sign of the patient: noninvasive blood pressure(NIBP, mm Hg)(Intraoperative)

Study Sites (1)

Loading locations...

Similar Trials